Clinical trial
Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers
NCT01360177 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers
- Lead sponsor
- Stanford University
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- July 31, 2010
- Completion date
- December 31, 2014
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, metastatic breast cancer